{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:37:52Z","timestamp":1776760672067,"version":"3.51.2"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11940-019-0579-9","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:03:32Z","timestamp":1562313812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Treatment Strategies for Neuroretinitis: Current Options and Emerging Therapies"],"prefix":"10.1007","volume":"21","author":[{"given":"Aaron M.","family":"Fairbanks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"issue":"6","key":"579_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/ICU.0000000000000527","volume":"29","author":"A Abdelhakim","year":"2018","unstructured":"\u2022\u2022 Abdelhakim A, Rasool N. Neuroretinitis: a review. Curr Opin Ophthalmol. 2018;29(6):514\u20139. The most up-to-date review on all aspects of neuroretinitis including the different etiologies as well as treatment options. The authors discuss the pros and cons of antibiotics vs no antibiotics for the management of cat scratch neuroretinitis.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"579_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0008-4182(01)80124-1","volume":"36","author":"D Pahor","year":"2001","unstructured":"Pahor D. Leber\u2019s idiopathic stellate neuroretinitis. Can J Ophthalmol. 2001;36(6):347\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"579_CR3","first-page":"763","volume":"83","author":"JD Gass","year":"1977","unstructured":"Gass JD. Diseases of the optic nerve that may simulate macular disease. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(5):763\u201370.","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"issue":"3","key":"579_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/WNO.0b013e3181b568c4","volume":"29","author":"H Kitamei","year":"2009","unstructured":"Kitamei H, Suzuki Y, Takahashi M, Katsuta S, Kato H, Yokoi M, et al. Retinal angiography and optical coherence tomography disclose focal optic disc vascular leakage and lipid-rich fluid accumulation within the retina in a patient with leber idiopathic stellate neuroretinitis. J Neuroophthalmol. 2009;29(3):203\u20137.","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"579_CR5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/archopht.1984.01040030924014","volume":"102","author":"CG Maitland","year":"1984","unstructured":"Maitland CG, Miller NR. Neuroretinitis. Arch Ophthalmol. 1984;102(8):1146\u201350.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"579_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7883\/yoken.JJID.2017.518","volume":"71","author":"H Celiker","year":"2018","unstructured":"Celiker H, Kazokoglu H, Eraslan M, Cerman E, Karabas L. Bartonella henselae neuroretinitis in patients without cat scratch. Jpn J Infect Dis. 2018;71(6):397\u2013401.","journal-title":"Jpn J Infect Dis"},{"issue":"2","key":"579_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0972-2327.41879","volume":"11","author":"SK Narayan","year":"2008","unstructured":"Narayan SK, Kaliaperumal S, Srinivasan R. Neuroretinitis, a great mimicker. Ann Indian Acad Neurol. 2008;11(2):109\u201313.","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"579_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00041327-200312000-00009","volume":"23","author":"MS Vaphiades","year":"2003","unstructured":"Vaphiades MS. Rocky Mountain Spotted Fever as a cause of macular star figure. J Neuroophthalmol. 2003;23(4):276\u20138.","journal-title":"J Neuroophthalmol"},{"key":"579_CR9","doi-asserted-by":"crossref","unstructured":"Reche-Sainz JA, Gracia Garcia-Miguel MT, Perez-Jacoiste MA. Papillitis and neuroretinitis of tuberculous etiology. Arch Soc Esp Oftalmol. 2019.","DOI":"10.1016\/j.oftale.2018.12.011"},{"issue":"3","key":"579_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000309629","volume":"192","author":"R Fusco","year":"1986","unstructured":"Fusco R, Magli A, Guacci P. Stellate maculopathy due to Salmonella typhi. A case report. Ophthalmologica. 1986;192(3):154\u20138.","journal-title":"Ophthalmologica"},{"issue":"3","key":"579_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/ijo.IJO_151_17","volume":"65","author":"BP Guliani","year":"2017","unstructured":"Guliani BP, Kumar S, Chawla N, Mehta A. Neuroretinitis as presenting and the only presentation of Lyme disease: diagnosis and management. Indian J Ophthalmol. 2017;65(3):250\u20132.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"579_CR12","doi-asserted-by":"publisher","first-page":"e33115","DOI":"10.5812\/ircmj.33115","volume":"18","author":"N Shoeibi","year":"2016","unstructured":"Shoeibi N, Hosseini SM, Bayani R. Toxoplasmosis neuroretinitis: a case report. Iran Red Crescent Med J. 2016;18(4):e33115.","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"579_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/0976-3147.98264","volume":"3","author":"LJ Basumatary","year":"2012","unstructured":"Basumatary LJ, Das S, Das M, Goswami M, Kayal AK. Leptospirosis presenting as neuroretinitis. J Neurosci Rural Pract. 2012;3(2):224\u20136.","journal-title":"J Neurosci Rural Pract"},{"issue":"1","key":"579_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1869-5760-3-5","volume":"3","author":"CG Besirli","year":"2013","unstructured":"Besirli CG, Elner SG. Retinal vasculitis in Toxocara canis neuroretinitis. J Ophthalmic Inflamm Infect. 2013;3(1):5.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ajoc.2018.07.002","volume":"11","author":"RY Choi","year":"2018","unstructured":"Choi RY, Lauer A, Rosenbaum JT. Molecular diagnosis and ocular imaging of varicella zoster virus associated neuroretinitis. Am J Ophthalmol Case Rep. 2018;11:146\u20138.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"579_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/WNO.0000000000000433","volume":"37","author":"YC Hsia","year":"2017","unstructured":"Hsia YC, Chin-Hong PV, Levin MH. Epstein-Barr virus neuroretinitis in a lung transplant patient. J Neuroophthalmol. 2017;37(1):43\u20137.","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"579_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0002-9394(77)90552-9","volume":"83","author":"BL Johnson","year":"1977","unstructured":"Johnson BL, Wisotzkey HM. Neuroretinitis associated with herpes simplex encephalitis in an adult. Am J Ophthalmol. 1977;83(4):481\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"579_CR18","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ophtha.2013.02.006","volume":"120","author":"RR Sivakumar","year":"2013","unstructured":"Sivakumar RR, Prajna L, Arya LK, Muraly P, Shukla J, Saxena D, et al. Molecular diagnosis and ocular imaging of West Nile virus retinitis and neuroretinitis. Ophthalmology. 2013;120(9):1820\u20136.","journal-title":"Ophthalmology."},{"key":"579_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.idcr.2017.06.010","volume":"9","author":"A Panday","year":"2017","unstructured":"Panday A, Sandy S, King D, Ramdeen S. A case of suspected symptomatic Zika Neuroretinitis. IDCases. 2017;9:104\u20135.","journal-title":"IDCases."},{"key":"579_CR20","unstructured":"Davila PJ, Toledo A, Ulloa-Padilla JP, Izquierdo NJ, Emanuelli A. Unilateral neuroretinitis as a late-onset manifestation of the chikungunya fever: a case series. Retin Cases Brief Rep. 2017:1."},{"issue":"1","key":"579_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00004397-200101000-00009","volume":"41","author":"S Ray","year":"2001","unstructured":"Ray S, Gragoudas E. Neuroretinitis. Int Ophthalmol Clin. 2001;41(1):83\u2013102.","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"579_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/archopht.1953.00920030365019","volume":"50","author":"M Fine","year":"1953","unstructured":"Fine M, Flocks M. Bilateral acute neuroretinitis with sarcoidosis treated with corticotropin and cortisone. AMA Arch Ophthalmol. 1953;50(3):358\u201362.","journal-title":"AMA Arch Ophthalmol"},{"issue":"3","key":"579_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000310477","volume":"208","author":"A Matsuda","year":"1994","unstructured":"Matsuda A, Chin S, Ohashi T. A case of neuroretinitis associated with long-standing polyarteritis nodosa. Ophthalmologica. 1994;208(3):168\u201371.","journal-title":"Ophthalmologica."},{"issue":"5","key":"579_CR24","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jfo.2014.06.023","volume":"38","author":"N Aigbe","year":"2015","unstructured":"Aigbe N, Bennouk Y, Madzou M, El Asri F, Chergui K, Brahime F, et al. Bilateral neuroretinitis secondary to Takayasu\u2019s arteritis in a young girl. J Fr Ophtalmol. 2015;38(5):e89.","journal-title":"J Fr Ophtalmol"},{"issue":"10","key":"579_CR25","first-page":"77","volume":"63","author":"G Santra","year":"2015","unstructured":"Santra G, Das I. Systemic lupus erythematosus presenting as neuroretinitis. J Assoc Physicians India. 2015;63(10):77\u20138.","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"579_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/01658107.2017.1327607","volume":"42","author":"F Pellegrini","year":"2018","unstructured":"Pellegrini F, Interlandi E, Prosdocimo G. Vogt-Koyanagi-Harada disease presenting as unilateral neuroretinits. Neuroophthalmology. 2018;42(1):11\u20136.","journal-title":"Neuroophthalmology"},{"issue":"1","key":"579_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","volume":"31","author":"V Purvin","year":"2011","unstructured":"Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuroophthalmol. 2011;31(1):58\u201368.","journal-title":"J Neuroophthalmol"},{"key":"579_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-14-5","volume":"14","author":"M Saito","year":"2014","unstructured":"Saito M, Saito W, Kanda A, Ohguro H, Ishida S. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and alpha-enolase. BMC Ophthalmol. 2014;14:5.","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"579_CR29","doi-asserted-by":"publisher","first-page":"e182928","DOI":"10.1001\/jamaophthalmol.2018.2928","volume":"136","author":"AR Lee","year":"2018","unstructured":"\u2022 Lee AR, El-Dairi MA. Anti-myelin oligodendrocyte glycoprotein optic neuritis or neuroretinitis? JAMA Ophthalmol. 2018;136(10):e182928. This case report highlights a patient with neuroretinitis who was discovered to have anti-MOG antibodies, indicating that anti-MOG ought to be excluded before labeling patients with idiopathic disease.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"579_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","volume":"38","author":"LA Dalvin","year":"2018","unstructured":"\u2022 Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: systemic indications and ophthalmic side effects. Retina. 2018;38(6):1063\u201378 In this review, the authors highlight the ophthalmic complications of the newer chemotherapy agents, checkpoint inhibitors, including neuroretinitis.","journal-title":"Retina"},{"issue":"1","key":"579_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12348-016-0082-3","volume":"6","author":"L Hahn","year":"2016","unstructured":"Hahn L, Pepple KL. Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. J Ophthalmic Inflamm Infect. 2016;6(1):14.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"579_CR32","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2147\/OPTH.S128506","volume":"11","author":"P Bajgai","year":"2017","unstructured":"Bajgai P, Katoch D, Dogra MR, Singh R. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clin Ophthalmol. 2017;11:1805\u201317.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"579_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archopht.121.1.65","volume":"121","author":"V Purvin","year":"2003","unstructured":"Purvin V, Ranson N, Kawasaki A. Idiopathic recurrent neuroretinitis: effects of long-term immunosuppression. Arch Ophthalmol. 2003;121(1):65\u20137.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"579_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/archopht.1994.01090150095030","volume":"112","author":"VA Purvin","year":"1994","unstructured":"Purvin VA, Chioran G. Recurrent neuroretinitis. Arch Ophthalmol. 1994;112(3):365\u201371.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"579_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1442-9071.2010.02298.x","volume":"38","author":"SV Sundaram","year":"2010","unstructured":"Sundaram SV, Purvin VA, Kawasaki A. Recurrent idiopathic neuroretinitis: natural history and effect of treatment. Clin Exp Ophthalmol. 2010;38(6):591\u20136.","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"579_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/eye.2011.125","volume":"25","author":"Z Habot-Wilner","year":"2011","unstructured":"Habot-Wilner Z, Zur D, Goldstein M, Goldenberg D, Shulman S, Kesler A, et al. Macular findings on optical coherence tomography in cat-scratch disease neuroretinitis. Eye (Lond). 2011;25(8):1064\u20138.","journal-title":"Eye (Lond)"},{"issue":"2","key":"579_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.WNO.0000165106.85989.1D","volume":"25","author":"MW Stewart","year":"2005","unstructured":"Stewart MW, Brazis PW, Barrett KM, Eidelman BH, Mendez JC. Optical coherence tomography in a case of bilateral neuroretinitis. J Neuroophthalmol. 2005;25(2):131\u20133.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"579_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/WNO.0000000000000501","volume":"37","author":"L Zatreanu","year":"2017","unstructured":"Zatreanu L, Sibony PA, Kupersmith MJ. Optical coherence tomography in neuroretinitis: epipapillary infiltrates and retinal folds. J Neuroophthalmol. 2017;37(2):176\u20138.","journal-title":"J Neuroophthalmol"},{"key":"579_CR39","doi-asserted-by":"crossref","unstructured":"Yamanuha JJYMM. Bartonella neuroretinitis: a case report with new insights from fundus autofluorescence. J Clin Exp Ophthalmol. 2014:445.","DOI":"10.4172\/2155-9570.1000445"},{"issue":"2","key":"579_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0161-6420(03)00663-8","volume":"111","author":"Kyle E Williams","year":"2004","unstructured":"Williams KE, Johnson LN. Neuroretinitis in patients with multiple sclerosis. Ophthalmology. 2004;111(2):335\u201340. discussion 40-1.","journal-title":"Ophthalmology"},{"issue":"10","key":"579_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/archneur.1987.00520220047015","volume":"44","author":"VC Parmley","year":"1987","unstructured":"Parmley VC, Schiffman JS, Maitland CG, Miller NR, Dreyer RF, Hoyt WF. Does neuroretinitis rule out multiple sclerosis? Arch Neurol. 1987;44(10):1045\u20138.","journal-title":"Arch Neurol"},{"issue":"8","key":"579_CR42","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s00247-007-0514-1","volume":"37","author":"AK Reddy","year":"2007","unstructured":"Reddy AK, Morriss MC, Ostrow GI, Stass-Isern M, Olitsky SE, Lowe LH. Utility of MR imaging in cat-scratch neuroretinitis. Pediatr Radiol. 2007;37(8):840\u20133.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"579_CR43","first-page":"1310","volume":"26","author":"IM Schmalfuss","year":"2005","unstructured":"Schmalfuss IM, Dean CW, Sistrom C, Bhatti MT. Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies. AJNR Am J Neuroradiol. 2005;26(6):1310\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"579_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ilar\/ilu015","volume":"55","author":"EB Breitschwerdt","year":"2014","unstructured":"Breitschwerdt EB. Bartonellosis: one health perspectives for an emerging infectious disease. ILAR J. 2014;55(1):46\u201358.","journal-title":"ILAR J"},{"issue":"4","key":"579_CR45","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1111\/aos.13684","volume":"96","author":"Z Habot-Wilner","year":"2018","unstructured":"\u2022 Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, et al. Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol. 2018;96(4):e524\u2013e32 Multicenter review of over 100 eyes that highlights the common ophthalmic manifestations of CSD. Additionally, the authors suggest antibiotics plus steriods improved acuity better than antibiotics alone.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"579_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0161-6420(00)00002-6","volume":"107","author":"EB Suhler","year":"2000","unstructured":"Suhler EB, Lauer AK, Rosenbaum JT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology. 2000;107(5):871\u20136.","journal-title":"Ophthalmology."},{"issue":"3","key":"579_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0161-6420(98)93028-7","volume":"105","author":"JB Reed","year":"1998","unstructured":"Reed JB, Scales DK, Wong MT, Lattuada CP Jr, Dolan MJ, Schwab IR. Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology. 1998;105(3):459\u201366.","journal-title":"Ophthalmology"},{"issue":"3","key":"579_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNO.0b013e318233a0a6","volume":"32","author":"A Gulati","year":"2012","unstructured":"Gulati A, Yalamanchili S, Golnik KC, Lee AG. Cat scratch neuroretinitis: the role of acute and convalescent titers for diagnosis. J Neuroophthalmol. 2012;32(3):243\u20135.","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"579_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/s-0035-1562899","volume":"36","author":"CA Hage","year":"2015","unstructured":"Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med. 2015;36(5):729\u201345.","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"579_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00006454-199806000-00002","volume":"17","author":"JW Bass","year":"1998","unstructured":"Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998;17(6):447\u201352.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"579_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/00006454-199206000-00010","volume":"11","author":"AM Margileth","year":"1992","unstructured":"Margileth AM. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J. 1992;11(6):474\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"579_CR52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/01913120701696510","volume":"31","author":"LH Pitassi","year":"2007","unstructured":"Pitassi LH, Magalhaes RF, Barjas-Castro ML, de Paula EV, Ferreira MR, Velho PE. Bartonella henselae infects human erythrocytes. Ultrastruct Pathol. 2007;31(6):369\u201372.","journal-title":"Ultrastruct Pathol"},{"issue":"2","key":"579_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0002-9394(14)72893-4","volume":"118","author":"KC Golnik","year":"1994","unstructured":"Golnik KC, Marotto ME, Fanous MM, Heitter D, King LP, Halpern JI, et al. Ophthalmic manifestations of Rochalimaea species. Am J Ophthalmol. 1994;118(2):145\u201351.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"579_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10792-010-9389-5","volume":"30","author":"AL Curi","year":"2010","unstructured":"Curi AL, Machado D, Heringer G, Campos WR, Lamas C, Rozental T, et al. Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol. 2010;30(5):553\u20138.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"579_CR55","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/WNO.0000000000000166","volume":"34","author":"MT Bhatti","year":"2014","unstructured":"Bhatti MT, Lee MS. Should patients with bartonella neuroretinitis receive treatment? J Neuroophthalmol. 2014;34(4):412\u20136.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"579_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00008480-200102000-00010","volume":"13","author":"DA Conrad","year":"2001","unstructured":"Conrad DA. Treatment of cat-scratch disease. Curr Opin Pediatr. 2001;13(1):56\u20139.","journal-title":"Curr Opin Pediatr"},{"key":"579_CR57","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of Bartonellosis. Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2017 [updated 05\/07\/2017. 1-5]. Available from: https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent-opportunistic-infection\/329\/bartonellosis. Accessed 1 May 2019."},{"issue":"2","key":"579_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1046\/j.1440-1606.1999.00174.x","volume":"27","author":"BS Rosen","year":"1999","unstructured":"Rosen BS, Barry CJ, Nicoll AM, Constable IJ. Conservative management of documented neuroretinitis in cat scratch disease associated with Bartonella henselae infection. Aust N Z J Ophthalmol. 1999;27(2):153\u20136.","journal-title":"Aust N Z J Ophthalmol"},{"issue":"8","key":"579_CR59","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0161-6420(99)90452-9","volume":"106","author":"WA Solley","year":"1999","unstructured":"Solley WA, Martin DF, Newman NJ, King R, Callanan DG, Zacchei T, et al. Cat scratch disease: posterior segment manifestations. Ophthalmology. 1999;106(8):1546\u201353.","journal-title":"Ophthalmology"},{"issue":"1","key":"579_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ophtha.2011.06.042","volume":"119","author":"SL Chi","year":"2012","unstructured":"Chi SL, Stinnett S, Eggenberger E, Foroozan R, Golnik K, Lee MS, et al. Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology. 2012;119(1):183\u20137.","journal-title":"Ophthalmology"},{"key":"579_CR61","unstructured":"Centers for Disease Control and Prevention - Bartonella infection (cat scratch disease, trench fever, and Carri\u00f3n\u2019s disease) 2014 [updated 12\/14\/2015]. Available from: https:\/\/www.cdc.gov\/bartonella\/clinicians\/index.html. Accessed 1 May 2019."},{"issue":"5","key":"579_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/practneurol-2015-001175","volume":"15","author":"A Attawan","year":"2015","unstructured":"Attawan A, Pepper IM, Hickman SJ. The natural history of idiopathic neuroretinitis. Pract Neurol. 2015;15(5):387\u20138.","journal-title":"Pract Neurol"},{"issue":"16","key":"579_CR63","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1001\/jama.2016.2884","volume":"315","author":"E Sanchez","year":"2016","unstructured":"Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315(16):1767\u201377.","journal-title":"JAMA"},{"key":"579_CR64","unstructured":"Centers for Disease Control and Prevention - Lyme disease 2018 [updated 12\/21\/2018. Available from: https:\/\/www.cdc.gov\/lyme\/treatment\/index.html. Accessed 1 May 2019."},{"issue":"9","key":"579_CR65","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC201605030","volume":"164","author":"LT Hu","year":"2016","unstructured":"Hu LT. Lyme disease. Ann Intern Med. 2016;164(9):ITC65\u201380.","journal-title":"Ann Intern Med"},{"issue":"8","key":"579_CR66","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","volume":"7","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690\u20135.","journal-title":"Lancet Neurol"},{"key":"579_CR67","unstructured":"The diagnosis, management and prevention of syphilis: an update and review \u2013 a clinical guidance document for use in the diagnosis and management of syphilis. Based on content from the 2015 CDC STD treatment guidelines, and developed by the NYC Department of Health and Mental Hygiene Bureau of Sexually Transmitted Infections and the NYC STD Prevention Training Center. March 2019."},{"key":"579_CR68","unstructured":"Centers for Disease Control and Prevention - 2015 Sexually transmitted diseases treatment guidelines: Syphilis.2015."},{"issue":"2","key":"579_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0161-6420(85)34045-9","volume":"92","author":"J Arruga","year":"1985","unstructured":"Arruga J, Valentines J, Mauri F, Roca G, Salom R, Rufi G. Neuroretinitis in acquired syphilis. Ophthalmology. 1985;92(2):262\u201370.","journal-title":"Ophthalmology"},{"issue":"18","key":"579_CR70","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1001\/jama.2014.13259","volume":"312","author":"ME Clement","year":"2014","unstructured":"Clement ME, Okeke NL, Hicks CB. Treatment of syphilis: a systematic review. JAMA. 2014;312(18):1905\u201317.","journal-title":"JAMA"},{"issue":"7","key":"579_CR71","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147\u2013e95.","journal-title":"Clin Infect Dis"},{"issue":"RR-11","key":"579_CR72","first-page":"1","volume":"52","author":"American Thoracic S, Cdc, Infectious Diseases Society of America","year":"2003","unstructured":"American Thoracic S, Cdc, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1\u201377.","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"579_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09273948.2010.489729","volume":"18","author":"NJ Cutrufello","year":"2010","unstructured":"Cutrufello NJ, Karakousis PC, Fishler J, Albini TA. Intraocular tuberculosis. Ocul Immunol Inflamm. 2010;18(4):281\u201391.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"579_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","volume":"65","author":"HM Biggs","year":"2016","unstructured":"Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016;65(2):1\u201344.","journal-title":"MMWR Recomm Rep"},{"key":"579_CR75","doi-asserted-by":"crossref","unstructured":"Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev. 2012;(2):CD008264.","DOI":"10.1002\/14651858.CD008264.pub2"},{"issue":"5","key":"579_CR76","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","volume":"166","author":"SR Todd","year":"2015","unstructured":"Todd SR, Dahlgren FS, Traeger MS, Beltran-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166(5):1246\u201351.","journal-title":"J Pediatr"},{"issue":"6","key":"579_CR77","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA. Intraocular tuberculosis--an update. Surv Ophthalmol. 2007;52(6):561\u201387.","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"579_CR78","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archopht.1984.01040030918013","volume":"102","author":"RF Dreyer","year":"1984","unstructured":"Dreyer RF, Hopen G, Gass JD, Smith JL. Leber\u2019s idiopathic stellate neuroretinitis. Arch Ophthalmol. 1984;102(8):1140\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"579_CR79","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1128\/IAI.72.12.7315-7317.2004","volume":"72","author":"JE Kirby","year":"2004","unstructured":"Kirby JE. In vitro model of Bartonella henselae-induced angiogenesis. Infect Immun. 2004;72(12):7315\u20137.","journal-title":"Infect Immun"},{"issue":"3","key":"579_CR80","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/09273940902731023","volume":"17","author":"M Cakir","year":"2009","unstructured":"Cakir M, Cekic O, Bozkurt E, Pekel G, Yazici AT, Yilmaz OF. Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis. Ocul Immunol Inflamm. 2009;17(3):221\u20133.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"579_CR81","doi-asserted-by":"publisher","first-page":"757","DOI":"10.5301\/ejo.5000301","volume":"23","author":"T Empeslidis","year":"2013","unstructured":"Empeslidis T, Banerjee S, Vardarinos A, Konstas AG. Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Eur J Ophthalmol. 2013;23(5):757\u201360.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"579_CR82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000375481","volume":"6","author":"AO Saatci","year":"2015","unstructured":"Saatci AO, Ayhan Z, Takes O, Yaman A, Bajin FM. Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral azathioprine treatment in IRVAN syndrome. Case Rep Ophthalmol. 2015;6(1):56\u201362.","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"579_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00417-019-04291-5","volume":"257","author":"YJ Chong","year":"2019","unstructured":"Chong YJ, Logeswaran A, Sarmad A, Damato EM. Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): case series of three patients with multimodal imaging. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):1013\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"579_CR84","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/jop.2010.0189","volume":"27","author":"RA Cheema","year":"2011","unstructured":"Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. 2011;27(4):407\u201310.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"579_CR85","first-page":"503","volume":"37","author":"C Fellner","year":"2012","unstructured":"Fellner C. Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. P T. 2012;37(9):503\u201330.","journal-title":"P T"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-019-0579-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-019-0579-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-019-0579-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:02:19Z","timestamp":1659096139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-019-0579-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s11940-019-0579-9","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"5 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Dr. Bhatti participated in the following two studies that involved human subjects: Schmalfuss IM, Dean CW, Sistrom C, Bhatti MT. Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies. AJNR Am J Neuroradiol. 2005;26 (6):1310\u20136; Chi SL, Stinnett S, Eggenberger E, Foroozan R, Golnik K, Lee MS, et al. Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology. 2012;119 (1):183\u20137.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"36"}}